LT
Leonid Timashev RBC Capital Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Jazz Pharmaceuticals
JAZZ
$7.99B
| $131.72 | $151 |
15%
upside
| Outperform | 6 days ago |
|
2
Xencor
XNCR
$594M
| $8.33 | $15 |
80%
upside
| Outperform | 13 days ago |
|
3
Insmed
INSM
$30.3B
| $143.50 | $138 |
4%
downside
| Outperform | 21 days ago |
|
4
Legend Biotech
LEGN
$6.64B
| $35.95 | $77 |
114%
upside
| Outperform | 22 days ago |
|
5
Verastem
VSTM
$585M
| $9.50 | $13 |
37%
upside
| Outperform | 26 days ago |
|
6
Nuvation Bio
NUVB
$1.08B
| $3.15 | $7 |
122%
upside
| Outperform | 26 days ago |
|
7
Edgewise Therapeutics
EWTX
$1.54B
| $14.63 | $49 |
235%
upside
| Outperform | 26 days ago |
|
8
NewAmsterdam Pharma
NAMS
$2.8B
| $24.88 | $39 |
57%
upside
| Outperform | 27 days ago |
|
|
ONC
9
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $336.26 | $364 |
8%
upside
| Outperform | 27 days ago |
|
10
Axsome Therapeutics
AXSM
$6.09B
| $122 | $189 |
55%
upside
| Outperform | 29 days ago |
|
11
Alkermes
ALKS
$4.95B
| $30 | $42 |
40%
upside
| Sector Perform | 1 month ago |
|
12
Exelixis
EXEL
$9.95B
| $36.96 | $45 |
22%
upside
| Sector Perform | 1 month ago |
|
|
BCYC
13
Bicycle Therapeutics
BCYC
$492M
| $7.10 | $25 |
252%
upside
| Outperform | 1 month ago |
|
14
CG Oncology
CGON
$2.19B
| $28.67 | $53 |
85%
upside
| Outperform | 1 month ago |
|
15
IDEAYA Biosciences
IDYA
$2.26B
| $25.76 | $30 |
16%
upside
| Outperform | 1 month ago |
|
16
CorMedix
CRMD
$1.02B
| $13.70 | $17 |
24%
upside
| Outperform | 2 months ago |
|
17
ADC Therapeutics
ADCT
$370M
| $3.29 | $5 |
52%
upside
| Outperform | 2 months ago |
|
18
Perspective Therapeutics
CATX
$251M
| $3.38 | $16 |
373%
upside
| Outperform | 3 months ago |
|
19
Biohaven
BHVN
$1.71B
| $16.21 | $21 |
30%
upside
| Sector Perform | 3 months ago |
|
20
Cytokinetics
CYTK
$5.98B
| $49.99 | $80 |
60%
upside
| Outperform | 3 months ago |
|
21
Incyte
INCY
$17B
| $86.96 | $70 |
20%
downside
| Sector Perform | 7 months ago |
|
|
CMPS
22
Compass Pathways
CMPS
$452M
| $4.71 | $18 |
282%
upside
| Outperform | 7 months ago |
|
23
Design Therapeutics
DSGN
$339M
| $5.96 | $4 |
33%
downside
| Sector Perform | 1 year ago |
|